Cancer and Circulating Tumor Cells

Rare cell capture from blood is exciting owing to the potential to derive clinical benefit with minimal inconvenience and discomfort to patients. Information derived from rare cells (e.g., fetal cells in mothers or cancer cells in cancer patients) can be used in lieu of information from biopsies and thus improve patient outcomes.

Microfluidic devices are ideally suited for these processes, owing to the flexibility of geometric design, wealth of chemical manipulation techniques, and assay compatibility of current systems. Stokes flow analysis is often a good predictor of the flows in these systems.

Archival CTC Publications

CTC Presentations

Figure Gallery

A selection of figures from relevant publications are below.  Click to open a carousel view.  Links to the original manuscript are in the captions.